Continuous Subcutaneous Insulin Infusion Therapy Market size was valued at USD 5.5 Billion in 2024 and is forecasted to grow at a CAGR of 6.2% from 2026 to 2033, reaching USD 9.1 Billion by 2033.
Market Overview: The Continuous Subcutaneous Insulin Infusion Therapy Market in South Korea has been experiencing significant growth. In 2023, the market generated a revenue of USD 44.4 million and is projected to reach USD 90.7 million by 2030, growing at a CAGR of 10.7% from 2024 to 2030. This growth is attributed to the increasing prevalence of diabetes and advancements in insulin delivery technologies.
Product Segmentation:
Tethered Pumps: Accounted for the largest revenue-generating product segment in 2023.
Patch Pumps: Identified as the most lucrative product segment, registering the fastest growth during the forecast period.
Industry Requirements: The rising demand for efficient and advanced insulin delivery systems is driving the need for:
Integration of artificial intelligence (AI) and the Internet of Things (IoT) in insulin pumps.
Development of user-friendly interfaces and programmable dosing features.
Real-time data tracking and wireless connectivity capabilities.
Key Market Players: The market is characterized by the presence of several key players, including:
Medtronic PLC
Tandem Diabetes Care Inc
CeQur Simplicity
Roche Holding AG ADR
Insulet Corp
Ypsomed Holding AG
SOOIL Developments
Market Drivers:
Increasing prevalence of diabetes in South Korea.
Implementation of various government initiatives to improve diabetes care.
Rapid technological advancements in insulin delivery devices.
Future Outlook: The Continuous Subcutaneous Insulin Infusion Therapy Market in South Korea is expected to continue its growth trajectory, driven by technological innovations and the increasing need for effective diabetes management solutions.
Get an In-Depth Research Analysis of the South Korea Continuous Subcutaneous Insulin Infusion Therapy Market Size And Forecast [2025-2032]
Â
Medtronic
Roche
SOOIL
Tandem Diabetes care
Insulet Corp
Valeritas
Microport
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Continuous Subcutaneous Insulin Infusion Therapy Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Continuous Subcutaneous Insulin Infusion Therapy Market
Insulin Pumps
Continuous Glucose Monitors (CGMs)
Smart Insulin Pens
Disposable Insulin Infusion Devices
Reusable Insulin Infusion Devices
Hybrid Closed-loop Systems
Hospitals and Clinics
Homecare Settings
Specialized Diabetes Care Centers
Pediatric Patients
Adult Patients
Seniors
Intravenous Delivery Systems
Subcutaneous Delivery Systems
Inhalation Delivery Systems
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Continuous Subcutaneous Insulin Infusion Therapy Market Research Analysis
1. Introduction of the South Korea Continuous Subcutaneous Insulin Infusion Therapy Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Continuous Subcutaneous Insulin Infusion Therapy Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Continuous Subcutaneous Insulin Infusion Therapy Market, By Type
6. South Korea Continuous Subcutaneous Insulin Infusion Therapy Market, By Application
7. South Korea Continuous Subcutaneous Insulin Infusion Therapy Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Continuous Subcutaneous Insulin Infusion Therapy Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/